From: Personalized life expectancy and treatment benefit index of antiretroviral therapy
Par. | P1 | P2 | P3 | P4 | P5 | P6 | P7 |
---|---|---|---|---|---|---|---|
β λ | 117.95 | 107.65 | 152.83 | 136.51 | 109.63 | 109.92 | 116.75 |
β k | 1542.68 | 1614.66 | 1873.36 | 1270.91 | 1476.14 | 1471.95 | 1606.20 |
α λ | 0.32 | 0.13 | 0.44 | 0.31 | 0.08 | 0.08 | 0.04 |
α k | 0.56 | 0.99 | 0.84 | 1.08 | 1.11 | 1.11 | 1.07 |
T m | 4014 | 3946.7 | 4571.1 | 3739.2 | 3995 | 4002.1 | 4019.7 |
η | 0.78 | 0.71 | 0.60 | 0.78 | 0.89 | 0.78 | 0.96 |
τ 50 | 117.89 | 39.34 | 383.85 | 30.23 | 52.64 | 55.92 | 31.76 |
τ m | 15915 | 18055 | 4496 | 7574 | 17382 | 17277 | 20596 |
q | 0.84 | 0.77 | 0.89 | 0.75 | 0.78 | 0.64 | 0.65 |
p | 3.72 | 8.13 | 1.23 | 13.96 | 1.89 | 2.19 | 3.14 |
\(\bar {\beta }_{k}\) | 73.35 | 1614.7 | 1869.7 | 12.70 | 1294.6 | 931.08 | 217.12 |
\(\bar {\alpha }_{k}\) | 0.56 | 0.99 | 0.84 | 0.80 | 1.10 | 1.11 | 1.07 |
l | 0.80 | 0.99 | 0.99 | 0.86 | 0.80 | 0.99 | 0.90 |
T s | 2983.6 | 3681 | 3290.4 | 3358.7 | 3719.5 | 3521 | 3839.7 |
T r | 3796.47 | 5070.56 | 3812.76 | 3929.77 | 5544.5 | 4424.67 | 4232.49 |
T e | 4279.6 | 5116 | 4592.1 | 4038.7 | 4909 | 4615.4 | 6706.3 |
T d | 18899.09 | 21736.01 | 7786.16 | 10932.50 | 21101.71 | 20798.12 | 24436.16 |
B CD4 | 200 | 100 | 200 | 50 | – | – | – |